Sunquest Announces Roper Technologies' Acquisition of CliniSys and Atlas Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
Roper Industries (ROP) Reports Strong 3Q Results; UBS Raises Price target to $205
October 27, 2015 11:41 AM EDTUBS reiterated a Buy rating on Roper Industries (NYSE: ROP), and raised the price target to $205.00 (from $200.00), following the company's 3Q15 earnings results. Roper reported 3Q15 adjusted EPS of $1.61, above consensus of $1.57 and compared to guidance of $1.53-$1.57.
A UBS analyst commented, "Roper... More
